Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives

被引:0
|
作者
Ijaz, M. Khalid [1 ]
Nims, Raymond W. [2 ]
McKinney, Julie [1 ]
机构
[1] Reckitt Benckiser LLC, Global Res & Dev Lysol & Dettol, One Phillips Dr, Montvale, NJ 07645 USA
[2] RMC Pharmaceut Solut, Longmont, CO 80501 USA
来源
LIFE-BASEL | 2022年 / 12卷 / 07期
关键词
coronavirus; COVID-19; decontamination of surfaces and hands; Beta variant; Delta variant; formulated microbicidal active; hierarchy of microbicidal susceptibility to pathogens; SARS-CoV-2; viral inactivation; virucidal efficacy; TRANSMISSION; OMICRON; COVID-19;
D O I
10.3390/life12070987
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is evolving, with emergence of mutational variants due to the error-prone replication process of RNA viruses, in general. More recently, the Delta and Omicron variants (including sub-variants BA.1-5) predominate globally, and a Delta-Omicron recombinant termed Deltacron has emerged. The emergence of variants of concern (VOC) demonstrating immune evasion and potentially greater transmissibility and virulence naturally raises concern in both the infection control communities and the public at large, as to the continued suitability of interventions intended to mitigate the risk of viral dissemination and acquisition of the associated disease COVID-19. We evaluated the virucidal efficacy of targeted surface hygiene products (an ethanol/quaternary ammonium compound (QAC)-containing disinfectant spray, a QAC disinfectant wipe, a lactic acid disinfectant wipe, and a citric acid disinfectant wipe) through both theoretical arguments and empirical testing using international standard methodologies (ASTM E1053-20 hard surface test and EN14476:2013+A2:2019 suspension test) in the presence of soil loads simulating patients' bodily secretions/excretions containing shed virus. The results demonstrate, as expected, complete infectious viral inactivation (>= 3.0 to >= 4.7 log(10) reduction in infectious virus titer after as little as 15 s contact time at room temperature) by these surface hygiene agents of the original SARS-CoV-2 isolate and its Beta and Delta VOC. Through appropriate practices of targeted surface hygiene, it is expected that irrespective of the SARS-CoV-2 VOC encountered as the current pandemic unfolds (and, for that matter, any emerging and/or re-emerging enveloped virus), the chain of infection from virus-contaminated fomites to the hand and mucous membranes of a susceptible person may be disrupted.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [2] SARS-CoV-2 variants of concern are emerging in India
    Jasdeep Singh
    Syed Asad Rahman
    Nasreen Z. Ehtesham
    Subhash Hira
    Seyed E. Hasnain
    [J]. Nature Medicine, 2021, 27 : 1131 - 1133
  • [3] The Emerging Concern and Interest SARS-CoV-2 Variants
    Janik, Edyta
    Niemcewicz, Marcin
    Podogrocki, Marcin
    Majsterek, Ireneusz
    Bijak, Michal
    [J]. PATHOGENS, 2021, 10 (06):
  • [4] SARS-CoV-2 variants of concern are emerging in India
    Singh, Jasdeep
    Rahman, Syed Asad
    Ehtesham, Nasreen Z.
    Hira, Subhash
    Hasnain, Seyed E.
    [J]. NATURE MEDICINE, 2021, 27 (07) : 1131 - 1133
  • [5] Microbicidal actives with virucidal efficacy against SARS-CoV-2
    Ijaz, M. Khalid
    Whitehead, Kelly
    Srinivasan, Vanita
    McKinney, Julie
    Rubino, Joseph R.
    Ripley, Mark
    Jones, Chris
    Nims, Raymond W.
    Charlesworth, Bruce
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (08) : 972 - 973
  • [6] Predicting the mutational drivers of future SARS-CoV-2 variants of concern
    Maher, M. Cyrus
    Bartha, Istvan
    Weaver, Steven
    di Iulio, Julia
    Ferri, Elena
    Soriaga, Leah
    Lempp, Florian A.
    Hie, Brian L.
    Bryson, Bryan
    Berger, Bonnie
    Robertson, David L.
    Snell, Gyorgy
    Corti, Davide
    Virgin, Herbert W.
    Pond, Sergei L. Kosakovsky
    Telenti, Amalio
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (633)
  • [7] A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
    Parray, Hilal Ahmad
    Narayanan, Naveen
    Garg, Sonal
    Rizvi, Zaigham Abbas
    Shrivastava, Tripti
    Kushwaha, Sachin
    Singh, Janmejay
    Murugavelu, Praveenkumar
    Anantharaj, Anbalagan
    Mehdi, Farha
    Raj, Nisha
    Singh, Shivam
    Dandotiya, Jyotsna
    Lukose, Asha
    Jamwal, Deepti
    Kumar, Sandeep
    Chiranjivi, Adarsh K.
    Dhyani, Samridhi
    Mishra, Nitesh
    Kumar, Sanjeev
    Jakhar, Kamini
    Sonar, Sudipta
    Panchal, Anil Kumar
    Tripathy, Manas Ranjan
    Chowdhury, Shirlie Roy
    Ahmed, Shubbir
    Samal, Sweety
    Mani, Shailendra
    Bhattacharyya, Sankar
    Das, Supratik
    Sinha, Subrata
    Luthra, Kalpana
    Batra, Gaurav
    Sehgal, Devinder
    Medigeshi, Guruprasad R.
    Sharma, Chandresh
    Awasthi, Amit
    Garg, Pramod Kumar
    Nair, Deepak T.
    Kumar, Rajesh
    [J]. PLOS PATHOGENS, 2022, 18 (12)
  • [8] The SARS-CoV-2 variants of concern
    Passi, Gouri Rao
    [J]. INDIAN PEDIATRICS, 2021, 58 (05) : 498 - 498
  • [9] SARS-CoV-2 Variants of Concern
    Choi, Jun Yong
    Smith, Davey M.
    [J]. YONSEI MEDICAL JOURNAL, 2021, 62 (11) : 961 - 968
  • [10] Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates
    Al-Sehemi, Abdullah G.
    Khan, Muhammad T.
    Muhammad, Shabbir
    [J]. SAUDI MEDICAL JOURNAL, 2021, 42 (12) : 1366 - 1368